QUANTUM CORP /DE/ — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that QUANTUM CORP /DE/ filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Mar 31, 2022 | $372.83M | Jun 8, 2022 |
| FY2022 | Mar 31, 2021 | $349.58M | Jun 8, 2022 |
| FY2022 | Mar 31, 2020 | $402.95M | Jun 8, 2022 |
| FY2019 | Mar 31, 2019 | $103.28M | Aug 6, 2019 |
| FY2019 | Dec 31, 2018 | $101.98M | Aug 6, 2019 |
| FY2019 | Sep 30, 2018 | $89.91M | Aug 6, 2019 |
| FY2019 | Jun 30, 2018 | $107.51M | Aug 6, 2019 |
| FY2019 | Mar 31, 2018 | $95.31M | Aug 6, 2019 |
| FY2019 | Dec 31, 2017 | $115.99M | Aug 6, 2019 |
| FY2019 | Sep 30, 2017 | $111.79M | Aug 6, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $274.06M | Aug 26, 2025 |
| FY2025 | Dec 31, 2024 | $68.68M | Aug 26, 2025 |
| FY2024 | Mar 31, 2024 | $71.50M | Jun 28, 2024 |
| FY2024 | Dec 31, 2023 | $71.93M | Jun 28, 2024 |
| FY2024 | Sep 30, 2023 | $75.68M | Jun 28, 2024 |
| FY2024 | Jun 30, 2023 | $92.50M | Jun 28, 2024 |
| FY2024 | Mar 31, 2023 | $109.20M | Jun 28, 2024 |
| FY2024 | Dec 31, 2022 | $113.48M | Jun 28, 2024 |
| FY2024 | Sep 30, 2022 | $100.57M | Jun 28, 2024 |
| FY2024 | Jun 30, 2022 | $98.83M | Jun 28, 2024 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $109.83M | Aug 26, 2025 |
| FY2025 | Dec 31, 2024 | $27.89M | Aug 26, 2025 |
| FY2024 | Mar 31, 2024 | $27.33M | Jun 28, 2024 |
| FY2024 | Dec 31, 2023 | $29.18M | Jun 28, 2024 |
| FY2024 | Sep 30, 2023 | $32.74M | Jun 28, 2024 |
| FY2024 | Jun 30, 2023 | $35.64M | Jun 28, 2024 |
| FY2024 | Mar 31, 2023 | $35.64M | Jun 28, 2024 |
| FY2024 | Dec 31, 2022 | $42.57M | Jun 28, 2024 |
| FY2024 | Sep 30, 2022 | $29.26M | Jun 28, 2024 |
| FY2024 | Jun 30, 2022 | $35.81M | Jun 28, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($115.09M) | Aug 26, 2025 |
| FY2025 | Dec 31, 2024 | ($75.30M) | Aug 26, 2025 |
| FY2024 | Mar 31, 2024 | ($18.94M) | Jun 28, 2024 |
| FY2024 | Dec 31, 2023 | ($9.87M) | Jun 28, 2024 |
| FY2024 | Sep 30, 2023 | ($3.33M) | Jun 28, 2024 |
| FY2024 | Jun 30, 2023 | ($9.14M) | Jun 28, 2024 |
| FY2024 | Mar 31, 2023 | ($10.18M) | Jun 28, 2024 |
| FY2024 | Dec 31, 2022 | $113.0K | Jun 28, 2024 |
| FY2024 | Sep 30, 2022 | ($7.42M) | Jun 28, 2024 |
| FY2024 | Jun 30, 2022 | ($879.0K) | Jun 28, 2024 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($41.68M) | Aug 26, 2025 |
| FY2025 | Dec 31, 2024 | ($7.73M) | Aug 26, 2025 |
| FY2024 | Mar 31, 2024 | ($13.81M) | Jun 28, 2024 |
| FY2024 | Dec 31, 2023 | ($6.22M) | Jun 28, 2024 |
| FY2024 | Sep 30, 2023 | ($3.71M) | Jun 28, 2024 |
| FY2024 | Jun 30, 2023 | ($5.14M) | Jun 28, 2024 |
| FY2024 | Mar 31, 2023 | ($5.67M) | Jun 28, 2024 |
| FY2024 | Dec 31, 2022 | $4.05M | Jun 28, 2024 |
| FY2024 | Sep 30, 2022 | ($9.74M) | Jun 28, 2024 |
| FY2024 | Jun 30, 2022 | ($5.32M) | Jun 28, 2024 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $31.14M | Aug 26, 2025 |
| FY2025 | Dec 31, 2024 | $7.68M | Aug 26, 2025 |
| FY2025 | Mar 31, 2024 | $38.05M | Aug 26, 2025 |
| FY2024 | Dec 31, 2023 | $8.76M | Jun 28, 2024 |
| FY2024 | Sep 30, 2023 | $9.15M | Jun 28, 2024 |
| FY2024 | Jun 30, 2023 | $10.91M | Jun 28, 2024 |
| FY2024 | Mar 31, 2023 | $44.56M | Jun 28, 2024 |
| FY2024 | Dec 31, 2022 | $11.25M | Jun 28, 2024 |
| FY2024 | Sep 30, 2022 | $10.55M | Jun 28, 2024 |
| FY2024 | Jun 30, 2022 | $12.13M | Jun 28, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($23.61M) | Aug 26, 2025 |
| FY2025 | Dec 31, 2024 | ($20.35M) | Aug 26, 2025 |
| FY2025 | Mar 31, 2024 | ($10.16M) | Aug 26, 2025 |
| FY2024 | Dec 31, 2023 | ($19.53M) | Jun 28, 2024 |
| FY2024 | Sep 30, 2023 | ($10.15M) | Jun 28, 2024 |
| FY2024 | Jun 30, 2023 | ($9.44M) | Jun 28, 2024 |
| FY2024 | Mar 31, 2023 | ($4.89M) | Jun 28, 2024 |
| FY2024 | Dec 31, 2022 | ($19.60M) | Jun 28, 2024 |
| FY2024 | Sep 30, 2022 | ($17.94M) | Jun 28, 2024 |
| FY2024 | Jun 30, 2022 | ($18.35M) | Jun 28, 2024 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $4.95M | Aug 26, 2025 |
| FY2025 | Dec 31, 2024 | $4.32M | Aug 26, 2025 |
| FY2025 | Mar 31, 2024 | $5.87M | Aug 26, 2025 |
| FY2024 | Dec 31, 2023 | $5.03M | Jun 28, 2024 |
| FY2024 | Sep 30, 2023 | $3.93M | Jun 28, 2024 |
| FY2024 | Jun 30, 2023 | $2.30M | Jun 28, 2024 |
| FY2024 | Mar 31, 2023 | $12.58M | Jun 28, 2024 |
| FY2024 | Dec 31, 2022 | $10.64M | Jun 28, 2024 |
| FY2024 | Sep 30, 2022 | $7.80M | Jun 28, 2024 |
| FY2024 | Jun 30, 2022 | $3.04M | Jun 28, 2024 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $155.40M | Aug 26, 2025 |
| FY2025 | Dec 31, 2024 | $168.06M | Aug 26, 2025 |
| FY2025 | Mar 31, 2024 | $187.62M | Aug 26, 2025 |
| FY2024 | Dec 31, 2023 | $199.21M | Jun 28, 2024 |
| FY2024 | Sep 30, 2023 | $194.81M | Jun 28, 2024 |
| FY2024 | Jun 30, 2023 | $210.48M | Jun 28, 2024 |
| FY2024 | Mar 31, 2023 | $213.66M | Jun 28, 2024 |
| FY2024 | Dec 31, 2022 | $232.40M | Jun 28, 2024 |
| FY2024 | Sep 30, 2022 | $209.68M | Jun 28, 2024 |
| FY2024 | Jun 30, 2022 | $221.67M | Jun 28, 2024 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $319.77M | Aug 26, 2025 |
| FY2025 | Dec 31, 2024 | $364.68M | Aug 26, 2025 |
| FY2025 | Mar 31, 2024 | $309.11M | Aug 26, 2025 |
| FY2024 | Dec 31, 2023 | $301.14M | Jun 28, 2024 |
| FY2024 | Sep 30, 2023 | $289.24M | Jun 28, 2024 |
| FY2024 | Jun 30, 2023 | $301.81M | Jun 28, 2024 |
| FY2024 | Mar 31, 2023 | $298.03M | Jun 28, 2024 |
| FY2024 | Dec 31, 2022 | $310.36M | Jun 28, 2024 |
| FY2024 | Sep 30, 2022 | $292.22M | Jun 28, 2024 |
| FY2024 | Jun 30, 2022 | $298.17M | Jun 28, 2024 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($164.37M) | Aug 26, 2025 |
| FY2025 | Dec 31, 2024 | ($196.62M) | Aug 26, 2025 |
| FY2025 | Sep 30, 2024 | ($151.10M) | Aug 26, 2025 |
| FY2025 | Mar 31, 2024 | ($121.50M) | Aug 26, 2025 |
| FY2024 | Dec 31, 2023 | ($101.93M) | Jun 28, 2024 |
| FY2024 | Sep 30, 2023 | ($94.43M) | Jun 28, 2024 |
| FY2024 | Jun 30, 2023 | ($91.32M) | Jun 28, 2024 |
| FY2025 | Mar 31, 2023 | ($84.37M) | Aug 26, 2025 |
| FY2024 | Dec 31, 2022 | ($77.96M) | Jun 28, 2024 |
| FY2024 | Sep 30, 2022 | ($82.54M) | Jun 28, 2024 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $12.97M | Aug 26, 2025 |
| FY2025 | Dec 31, 2024 | $12.97M | Aug 26, 2025 |
| FY2025 | Mar 31, 2024 | $12.97M | Aug 26, 2025 |
| FY2024 | Dec 31, 2023 | $12.97M | Jun 28, 2024 |
| FY2024 | Sep 30, 2023 | $12.97M | Jun 28, 2024 |
| FY2024 | Jun 30, 2023 | $12.97M | Jun 28, 2024 |
| FY2024 | Mar 31, 2023 | $12.97M | Jun 28, 2024 |
| FY2024 | Dec 31, 2022 | $12.97M | Jun 28, 2024 |
| FY2024 | Sep 30, 2022 | $12.97M | Jun 28, 2024 |
| FY2024 | Jun 30, 2022 | $12.97M | Jun 28, 2024 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($942.47M) | Aug 26, 2025 |
| FY2025 | Dec 31, 2024 | ($934.73M) | Aug 26, 2025 |
| FY2025 | Mar 31, 2024 | ($827.38M) | Aug 26, 2025 |
| FY2024 | Dec 31, 2023 | ($808.44M) | Jun 28, 2024 |
| FY2024 | Sep 30, 2023 | ($798.57M) | Jun 28, 2024 |
| FY2024 | Jun 30, 2023 | ($795.24M) | Jun 28, 2024 |
| FY2024 | Mar 31, 2023 | ($786.09M) | Jun 28, 2024 |
| FY2024 | Dec 31, 2022 | ($775.91M) | Jun 28, 2024 |
| FY2024 | Sep 30, 2022 | ($776.03M) | Jun 28, 2024 |
| FY2024 | Jun 30, 2022 | ($768.60M) | Jun 28, 2024 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $16.46M | Aug 26, 2025 |
| FY2025 | Dec 31, 2024 | $20.38M | Aug 26, 2025 |
| FY2025 | Mar 31, 2024 | $25.69M | Aug 26, 2025 |
| FY2024 | Dec 31, 2023 | $24.38M | Jun 28, 2024 |
| FY2024 | Sep 30, 2023 | $25.57M | Jun 28, 2024 |
| FY2024 | Jun 30, 2023 | $25.47M | Jun 28, 2024 |
| FY2024 | Mar 31, 2023 | $25.96M | Jun 28, 2024 |
| FY2024 | Dec 31, 2022 | $26.03M | Jun 28, 2024 |
| FY2024 | Sep 30, 2022 | $25.70M | Jun 28, 2024 |
| FY2024 | Jun 30, 2022 | $26.53M | Jun 28, 2024 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $0 | Aug 26, 2025 |
| FY2025 | Mar 31, 2024 | $0 | Aug 26, 2025 |
| FY2024 | Mar 31, 2023 | $83.10M | Jun 28, 2024 |
| FY2024 | Mar 31, 2022 | $107.18M | Jun 28, 2024 |
| FY2022 | Mar 31, 2021 | $90.89M | Jun 8, 2022 |
| FY2021 | Mar 31, 2020 | $146.85M | May 26, 2021 |
| FY2019 | Mar 31, 2019 | $164.59M | Aug 6, 2019 |
| FY2019 | Mar 31, 2018 | $115.99M | Aug 6, 2019 |
| FY2017 | Mar 31, 2017 | $131.59M | Jun 1, 2017 |
| FY2016 | Mar 31, 2016 | $135.71M | Jun 3, 2016 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | (22) | Aug 26, 2025 |
| FY2025 | Dec 31, 2024 | (15) | Aug 26, 2025 |
| FY2024 | Mar 31, 2024 | 0 | Jun 28, 2024 |
| FY2024 | Dec 31, 2023 | 0 | Jun 28, 2024 |
| FY2024 | Sep 30, 2023 | 0 | Jun 28, 2024 |
| FY2024 | Jun 30, 2023 | 0 | Jun 28, 2024 |
| FY2024 | Mar 31, 2023 | 0 | Jun 28, 2024 |
| FY2024 | Dec 31, 2022 | 0 | Jun 28, 2024 |
| FY2024 | Sep 30, 2022 | 0 | Jun 28, 2024 |
| FY2024 | Jun 30, 2022 | 0 | Jun 28, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | (22) | Aug 26, 2025 |
| FY2025 | Dec 31, 2024 | (15) | Aug 26, 2025 |
| FY2025 | Mar 31, 2024 | (8) | Aug 26, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Jun 28, 2024 |
| FY2024 | Sep 30, 2023 | 0 | Jun 28, 2024 |
| FY2024 | Jun 30, 2023 | 0 | Jun 28, 2024 |
| FY2024 | Mar 31, 2023 | 0 | Jun 28, 2024 |
| FY2024 | Dec 31, 2022 | 0 | Jun 28, 2024 |
| FY2024 | Sep 30, 2022 | 0 | Jun 28, 2024 |
| FY2024 | Jun 30, 2022 | 0 | Jun 28, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 6.96M | Aug 26, 2025 |
| FY2025 | Dec 31, 2024 | 5.31M | Aug 26, 2025 |
| FY2025 | Aug 26, 2024 | 4.80M | Aug 26, 2025 |
| FY2025 | Aug 25, 2024 | 95.90M | Aug 26, 2025 |
| FY2025 | Mar 31, 2024 | 4.79M | Aug 26, 2025 |
| FY2024 | Dec 31, 2023 | 95.85M | Jun 28, 2024 |
| FY2024 | Mar 31, 2023 | 93.57M | Jun 28, 2024 |
| FY2024 | Dec 31, 2022 | 93.14M | Jun 28, 2024 |
| FY2024 | Jun 30, 2022 | 90.61M | Jun 28, 2024 |
| FY2024 | Mar 31, 2022 | 60.43M | Jun 28, 2024 |